These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26950705)

  • 41. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
    Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
    Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs.
    Martini WZ; Cortez DS; Dubick MA; Park MS; Holcomb JB
    J Trauma; 2008 Sep; 65(3):535-43. PubMed ID: 18784565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Edoxaban: Impact on routine and specific coagulation assays. A practical laboratory guide.
    Douxfils J; Chatelain B; Chatelain C; Dogné JM; Mullier F
    Thromb Haemost; 2016 Jan; 115(2):368-81. PubMed ID: 26510969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro investigation of the effects of exogenous sugammadex on coagulation in orthopedic surgical patients.
    Lee IO; Kim YS; Chang HW; Kim H; Lim BG; Lee M
    BMC Anesthesiol; 2018 May; 18(1):56. PubMed ID: 29793426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate.
    Dinkelaar J; Patiwael S; Harenberg J; Leyte A; Brinkman HJ
    Clin Chem Lab Med; 2014 Nov; 52(11):1615-23. PubMed ID: 24902009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-dose fibrinogen versus a clinically recommended dose of fresh frozen plasma for reversal of dilutional coagulopathy in an in vitro model of severe hemodilution.
    Rosenthal C; Rau J; Volk T; Sander M; Ziemer S; Von Heymann C
    Minerva Anestesiol; 2014 Aug; 80(8):894-903. PubMed ID: 24398441
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How the direct oral anticoagulant apixaban affects thrombin generation parameters.
    Tripodi A; Padovan L; Veena C; Scalambrino E; Testa S; Peyvandi F
    Thromb Res; 2015 Jun; 135(6):1186-90. PubMed ID: 25895845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of hemodilution on coagulation and recombinant factor VIIa efficacy in human blood in vitro.
    Darlington DN; Delgado AV; Kheirabadi BS; Fedyk CG; Scherer MR; Pusateri AE; Wade CE; Cap AP; Holcomb JB; Dubick MA
    J Trauma; 2011 Nov; 71(5):1152-63. PubMed ID: 21610535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypothermia and acidosis synergistically impair coagulation in human whole blood.
    Dirkmann D; Hanke AA; Görlinger K; Peters J
    Anesth Analg; 2008 Jun; 106(6):1627-32. PubMed ID: 18499589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of blood lipids on global coagulation test results.
    Kim JA; Kim JE; Song SH; Kim HK
    Ann Lab Med; 2015 Jan; 35(1):15-21. PubMed ID: 25553275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-FXa assays.
    Hillarp A; Gustafsson KM; Faxälv L; Strandberg K; Baghaei F; Fagerberg Blixter I; Berndtsson M; Lindahl TL
    J Thromb Haemost; 2014 Sep; 12(9):1545-53. PubMed ID: 24965851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A step change in oral anticoagulation: lack of coagulation monitoring with ximelagatran.
    Carlsson SC; Schulman S
    Semin Vasc Med; 2005 Aug; 5(3):259-65. PubMed ID: 16123913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Study of anticoagulant activity of ethanol extracts from leech in vitro].
    Feng GJ; Zhu ZG; Yu CL; Zhang Q; Chen NN; Lei LS; Wu SG
    Zhong Yao Cai; 2007 Aug; 30(8):909-11. PubMed ID: 18074833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The significance of TFPI in clotting assays--comparison and combination with other anticoagulants.
    Nordfang O; Kristensen HI; Valentin S; Ostergaard P; Wadt J
    Thromb Haemost; 1993 Sep; 70(3):448-53. PubMed ID: 8259547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of dabigatran and rivaroxaban on routine coagulation assays. A nationwide Belgian survey.
    Van Blerk M; Bailleul E; Chatelain B; Demulder A; Devreese K; Douxfils J; Jochmans K; Mullier F; Wijns W; Soumali MR; Coucke W; Vernelen K; Van de Walle P
    Thromb Haemost; 2015 Jan; 113(1):154-64. PubMed ID: 25231101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of ABO type on global coagulation assay results: effect of coagulation factor VIII.
    Choi Q; Kim JE; Kim SY; Han KS; Kim HK
    Clin Chem Lab Med; 2015 Aug; 53(9):1425-32. PubMed ID: 25503670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of freezing plasma at -20°C for 2 weeks on prothrombin time, activated partial thromboplastin time, dilute Russell viper venom time, activated protein C resistance, and D-dimer levels.
    Foshat M; Bates S; Russo W; Huerta A; Albright K; Giddings K; Indrikovs A; Qian YW
    Clin Appl Thromb Hemost; 2015 Jan; 21(1):41-7. PubMed ID: 24842886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biochemical and pharmacological effects of the direct thrombin inhibitor AR-H067637.
    Deinum J; Mattsson C; Inghardt T; Elg M
    Thromb Haemost; 2009 Jun; 101(6):1051-9. PubMed ID: 19492147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
    Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK
    Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Significantly different coagulation factor activities underlying the variability of 'normal' activated partial thromboplastin time.
    Park KJ; Kwon EH; Ma Y; Park IA; Kim SW; Kim SH; Kim HJ
    Blood Coagul Fibrinolysis; 2012 Jan; 23(1):35-8. PubMed ID: 22027757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.